BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lindsay SL, Barnett SC. Therapeutic Potential of Niche-Specific Mesenchymal Stromal Cells for Spinal Cord Injury Repair. Cells 2021;10:901. [PMID: 33919910 DOI: 10.3390/cells10040901] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Pang Q, Qian N, Zou W, Yang Y, Chen H, Zhang M, Zhang Q, Ao J, Zhang T. PBMSCs transplantation facilitates functional recovery after spinal cord injury by regulating microglia/macrophages plasticity. Transplant Immunology 2022;72:101592. [DOI: 10.1016/j.trim.2022.101592] [Reference Citation Analysis]
2 Fan C, Liao M, Xie L, Huang L, Lv S, Cai S, Su X, Wang Y, Wang H, Wang M, Liu Y, Wang Y, Guo H, Yang H, Liu Y, Wang T, Ma L. Single-Cell Transcriptome Integration Analysis Reveals the Correlation Between Mesenchymal Stromal Cells and Fibroblasts. Front Genet 2022;13:798331. [PMID: 35360851 DOI: 10.3389/fgene.2022.798331] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Lindsay SL, Molęda AM, MacLellan LM, Keh SM, McElroy DE, Linington C, Goodyear CS, Barnett SC. Human olfactory mesenchymal stromal cell transplantation ameliorates experimental autoimmune encephalomyelitis revealing an inhibitory role for IL16 on myelination. Acta Neuropathol Commun 2022;10:12. [PMID: 35093166 DOI: 10.1186/s40478-022-01316-9] [Reference Citation Analysis]
4 Pang Q, Chen S, Fu S, Zhou H, Zhang Q, Ao J, Luo X, Zhang T. Regulatory Role of Mesenchymal Stem Cells on Secondary Inflammation in Spinal Cord Injury. JIR 2022;Volume 15:573-93. [DOI: 10.2147/jir.s349572] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Pang QM, Chen SY, Xu QJ, Fu SP, Yang YC, Zou WH, Zhang M, Liu J, Wan WH, Peng JC, Zhang T. Neuroinflammation and Scarring After Spinal Cord Injury: Therapeutic Roles of MSCs on Inflammation and Glial Scar. Front Immunol 2021;12:751021. [PMID: 34925326 DOI: 10.3389/fimmu.2021.751021] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
6 Köhli P, Otto E, Jahn D, Reisener MJ, Appelt J, Rahmani A, Taheri N, Keller J, Pumberger M, Tsitsilonis S. Future Perspectives in Spinal Cord Repair: Brain as Saviour? TSCI with Concurrent TBI: Pathophysiological Interaction and Impact on MSC Treatment. Cells 2021;10:2955. [PMID: 34831179 DOI: 10.3390/cells10112955] [Reference Citation Analysis]
7 Wu C, Chen S, Zhou T, Wu K, Qiao Z, Zhang Y, Xin N, Liu X, Wei D, Sun J, Luo H, Zhou L, Fan H. Antioxidative and Conductive Nanoparticles-Embedded Cell Niche for Neural Differentiation and Spinal Cord Injury Repair. ACS Appl Mater Interfaces 2021. [PMID: 34699166 DOI: 10.1021/acsami.1c14679] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
8 Herrmann JL. Commentary: Another iteration of cell-based therapy for acute ischemia-reperfusion injury, this time in the spine. JTCVS Open 2021;7:41-42. [DOI: 10.1016/j.xjon.2021.06.021] [Reference Citation Analysis]
9 Bonaventura G, Munafò A, Bellanca CM, La Cognata V, Iemmolo R, Attaguile GA, Di Mauro R, Di Benedetto G, Cantarella G, Barcellona ML, Cavallaro S, Bernardini R. Stem Cells: Innovative Therapeutic Options for Neurodegenerative Diseases? Cells 2021;10:1992. [PMID: 34440761 DOI: 10.3390/cells10081992] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]